TREATMENT OF VIRAL RESPIRATORY INFECTIONS

Chaire Francqui - 27 mars 2003

Click here to start

Table of Contents

TREATMENT OF VIRAL RESPIRATORYINFECTIONS

RESPIRATORY TRACT VIRUS INFECTIONS

RESPIRATORY TRACT VIRAL DISEASES

INFLUENZA VIRUS

Influenza virus neuraminidase

NEURAMINIDASE INHIBITORS

Oseltamivir = GS4104 = oral prodrug (ethyl ester) form of GS4071

Zanamivir (Relenza®)

Oseltamivir (Tamiflu®)

RESISTANCE MUTATIONS TO NEURAMINIDASE INHIBITORS

Benefits offered by neuraminidase inhibitors

Characteristics of the proteins of respiratory syncytial virus and parainfluenza virus

CONCLUSIONAPPROVED ANTIVIRAL DRUGS FOR THE TREATMENT OF THE MAJOR RESPIRATORY TRACT VIRUS INFECTIONS

Author: Erik De Clercq

Email: tulkens@facm.ucl.ac.be

Home Page: http://www.md.ucl.ac.be/chaire-francqui/slides

Other information:
These slides are for information only. Do not make public use of them without the autorization of Prof. E. De Clercq and the organizers of the "Chaire Francqui". Please, adress your request to <tulkens@facm.ucl.ac.be>

Download presentation as PDF file (3.2 Mb)